Last chance to apply for our MedTech Venture Builder

A truly unique opportunity for UK MedTech startups.

The MedTech Venture Builder is a 12-month structured programme in two stages to help accelerate the translation of promising medical technologies into robust, investment-ready healthcare ventures.

Our collaborative focus on MedTech allows us to take ventures a significant step further than what has been achieved before programmatically. We will provide the structures that are critical to a robust MedTech company, such as a regulatory plan, a clinical evidence roadmap and stakeholder mapping, extensive hands-on guidance and monthly strategic progress reviews, all within a fit-for-purpose Quality Management System (QMS).

This is a truly unique opportunity for very select, high-potential MedTech companies from across the UK to receive fully customised, extensive executive support from experts in commercial translation from the partner institutions.

If you are a MedTech startup looking for the best support from the ecosystem, don’t miss this opportunity to apply now.

Supporting companies from across the UK, the MedTech Venture Builder, the first of its kind, is a collaborative effort between London’s leading academic institutions, King’s College London (lead), Queen Mary University London, City, University of London, and St. George’s University London.